TicTwo Therapeutics
Revolutionizing Neurodegenerative Disease Treatment
TicTwo Therapeutics is a pre-clinical stage biotech company developing TYK2 inhibitors targeting neurodegenerative diseases.
As TicTwo Therapeutics prepared to initiate their Series A outreach, they engaged Merz to create the brand assets needed to support those efforts.
